speb/financial-data huggingface dataset:
Financial ratios for 8096.HK — annual report dated 2023-03-31
Total revenue: 5385095.5414012745
Gross profit: 1722038.2165605095
Operating income: -1041019.1082802549
Net income: -1229299.363057325
Capital expenditures: 396178.3439490446
Operating cash flow: -99363.05732484077
Depreciation & amortization: 519363.0573248408
Net tangible assets: 482675.15923566883
Owner earnings: -1106114.6496815286
Return on net tangible assets (%): -229.1633676431776
Buffett classification: The Gruesome
Stock price: 0.03694267515923567
Shares outstanding: 242218543
Book value: 220509.55414012726
P/B ratio: 40.579651917966515
Market cap (USD): 8948200.951592356
Debt to equity: 8.331022530329294
Current ratio: 0.6699652867727061
Quick ratio: 0.6393969224392518
Interest coverage ratio: -11.118367346938777
COGS to revenue (%): 68.02214179263359
R&D to revenue (%): 1.594398315709791
SG&A to revenue (%): 10.200364298724955
Free cash flow (dilution-adjusted): -868280.2547770701
Buyback yield (%): 0
Retained earnings: -10296178.343949044
Inventory turnover: 48.73728813559322
Receivables turnover: 7.355663824604141
Capitalized R&D asset: 182466.5137353475
ROCI (R&D-adjusted, %): -72.24778902107866
Rosenberg metric: 2.833090554179618
FCF margin (%): -16.123766943439076
Revenue growth (%): 0.6908446106886474
Rule of 40 score: -15.43292233275043
Financial ratios for 8096.HK — annual report dated 2024-03-31
Total revenue: 4889910.600255428
Gross profit: 1684163.4738186463
Operating income: -776756.0664112389
Net income: -1037803.3205619412
Capital expenditures: 1591698.595146871
Operating cash flow: -197062.57982120052
Depreciation & amortization: 674329.5019157088
Net tangible assets: 2836781.6091954024
Owner earnings: -1955172.4137931033
Return on net tangible assets (%): -68.92220421393841
Buffett classification: The Gruesome
Stock price: 0.024296675191815855
Shares outstanding: 242218543
Book value: 2574840.3575989786
P/B ratio: 2.2856194743637244
Market cap (USD): 5885105.264705882
Debt to equity: 0.1393780070433014
Current ratio: 1.24479322074357
Quick ratio: 1.2329175866801934
Interest coverage ratio: -10.764601769911504
COGS to revenue (%): 65.5583994985374
R&D to revenue (%): 1.2719389887170913
SG&A to revenue (%): 9.702778938570832
Free cash flow (dilution-adjusted): -1788761.1749680715
Buyback yield (%): 0
Retained earnings: -11361174.96807152
Inventory turnover: 126.1356783919598
Receivables turnover: 5.171957314602189
Capitalized R&D asset: 167305.16956666746
ROCI (R&D-adjusted, %): -29.34847937712986
Rosenberg metric: -0.4411227455840155
FCF margin (%): -36.58065190137903
Revenue growth (%): -9.19547178576135
Rule of 40 score: -45.77612368714038
Financial ratios for 8096.HK — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 2405405.4054054054
Buffett classification: The Gruesome
Stock price: 0.014157014157014158
Shares outstanding: 242218543
Book value: 2132561.1325611323
P/B ratio: 1.6079686016898012
Market cap (USD): 3429091.3423423427
Debt to equity: 0.22051901025950515
Current ratio: 0.9351244623087229
Quick ratio: 0.9313165503138002
Buyback yield (%): 0
Retained earnings: -11893693.693693694
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8096.HK — annual report dated 2025-03-31
Total revenue: 3973778.9203084833
Gross profit: 1797300.7712082262
Operating income: -754627.2493573264
Net income: -780591.2596401029
Capital expenditures: 395886.8894601542
Operating cash flow: 8097.6863753213365
Depreciation & amortization: 746915.1670951156
Net tangible assets: 2074164.5244215939
Owner earnings: -429562.98200514144
Return on net tangible assets (%): -20.71016917642685
Buffett classification: The Gruesome
Stock price: 0.016709511568123392
Shares outstanding: 242218543
Book value: 1799871.4652956298
P/B ratio: 2.248690322787974
Market cap (USD): 4047353.5462724934
Debt to equity: 0.122259515818039
Current ratio: 0.8557959709692736
Quick ratio: 0.8557959709692736
Interest coverage ratio: -32.61666666666667
COGS to revenue (%): 54.770992366412216
R&D to revenue (%): 1.190322163281149
SG&A to revenue (%): 16.350756889636433
Free cash flow (dilution-adjusted): -387789.2030848329
Buyback yield (%): 0
Retained earnings: -12214781.49100257
Receivables turnover: 5.318424221572338
Capitalized R&D asset: 117306.30439350902
ROCI (R&D-adjusted, %): -39.55876687765169
Rosenberg metric: 1.8190247198365728
FCF margin (%): -9.758700996247896
Revenue growth (%): -18.735141699708986
Rule of 40 score: -28.493842695956882
Financial ratios for 8096.HK — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 2074164.5244215939
Buffett classification: The Gruesome
Stock price: 0.016709511568123392
Shares outstanding: 242218543
Book value: 1799871.4652956298
P/B ratio: 2.248690322787974
Market cap (USD): 4047353.5462724934
Debt to equity: 0.122259515818039
Current ratio: 0.8557959709692736
Quick ratio: 0.8557959709692736
Buyback yield (%): 0
Retained earnings: -12214781.49100257
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8135.T — annual report dated 2022-03-31
Total revenue: 366841501.3932142
Gross profit: 68603507.62170136
Operating income: 4073102.770037699
Net income: 5925258.154400918
Capital expenditures: 180298.31175217178
Operating cash flow: 3581380.101622685
Depreciation & amortization: 1262088.1822652025
Net tangible assets: 90395017.2102934
Owner earnings: 7007048.024913948
Return on net tangible assets (%): 7.751586582048957
Capex to operating income (%): 4.426559356136821
Buffett classification: The Great
Stock price: 1.7849532863465007
P/E ratio: 5.896791004979255
Shares outstanding: 19574747
Book value: 91689886.90378627
P/B ratio: 0.38106720563103325
Market cap (USD): 34940008.98705131
Debt to equity: 0.047461565963532355
Current ratio: 1.6463011609185663
Quick ratio: 1.3464960596559614
Effective tax rate (%): 9.962640099626402
Interest coverage ratio: 248.50000000000003
COGS to revenue (%): 81.29886957687324
SG&A to revenue (%): 3.1008444662883696
Free cash flow (dilution-adjusted): 2565153.2535649897
Buyback yield (%): 0
Retained earnings: 43607605.31060482
Inventory turnover: 10.28575466365178
Receivables turnover: 5.107485166590598
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6793011548711867
FCF margin (%): 0.6992538313748269
Rule of 40 score: 0.6992538313748269
Financial ratios for 8135.T — annual report dated 2023-03-31
Total revenue: 374527027.0270271
Gross profit: 68761261.26126127
Operating income: 7515015.015015015
Net income: 6794294.294294295
Capital expenditures: 555555.5555555556
Operating cash flow: 11066066.066066068
Depreciation & amortization: 983483.4834834835
Net tangible assets: 96118618.61861862
Owner earnings: 7222222.222222222
Return on net tangible assets (%): 7.513863938139497
Capex to operating income (%): 7.392607392607394
Buffett classification: The Great
Stock price: 1.94512012012012
P/E ratio: 5.604001326220994
Shares outstanding: 19574747
Book value: 97102102.1021021
P/B ratio: 0.39211544767511985
Market cap (USD): 38075234.23596096
Debt to equity: 0.025127570743776098
Current ratio: 1.6191257645830228
Quick ratio: 1.3016559749365957
Effective tax rate (%): 25.73770491803279
Interest coverage ratio: 1000.9999999999999
COGS to revenue (%): 81.64050754705634
SG&A to revenue (%): 2.8624691803475852
Free cash flow (dilution-adjusted): 10390390.39039039
Buyback yield (%): 0
Retained earnings: 46021021.02102102
Inventory turnover: 9.569548872180452
Receivables turnover: 5.28912213740458
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.476030277544155
FCF margin (%): 2.774269849860685
Revenue growth (%): 2.09505347803459
Rule of 40 score: 4.869323327895275
Financial ratios for 8135.T — annual report dated 2024-03-31
Total revenue: 343086370.8399366
Gross profit: 60202060.22187005
Operating income: 5810882.197569995
Net income: 5348652.9318542
Capital expenditures: 798996.3021658743
Operating cash flow: 4516640.253565769
Depreciation & amortization: 977284.7332276809
Net tangible assets: 87209455.8901215
Owner earnings: 5526941.362916007
Return on net tangible assets (%): 6.337548269856893
Capex to operating income (%): 13.749999999999998
Buffett classification: The Great
Stock price: 1.9071579503433702
P/E ratio: 6.979726454987654
Shares outstanding: 19574747
Book value: 87856576.86212362
P/B ratio: 0.4249213399879744
Market cap (USD): 37332134.367010035
Debt to equity: 0.018113491168733557
Current ratio: 1.6169104530859795
Quick ratio: 1.3115947199429183
Effective tax rate (%): 20.666013712047015
Interest coverage ratio: 880
COGS to revenue (%): 82.4508728371538
SG&A to revenue (%): 2.750351251996843
Free cash flow (dilution-adjusted): 3664817.7496038037
Buyback yield (%): 0
Retained earnings: 44796619.12308505
Inventory turnover: 10.01145127366207
Receivables turnover: 5.27750126968004
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.66864210255089
FCF margin (%): 1.068191004099544
Revenue growth (%): -8.39476297255888
Rule of 40 score: -7.326571968459335
Financial ratios for 8135.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 97065415.3242751
Buffett classification: The Gruesome
Stock price: 2.1779661016949152
Shares outstanding: 19574747
Book value: 97618714.10561705
P/B ratio: 0.4367311719464772
Market cap (USD): 42633135.415254235
Debt to equity: 0.010187975319271056
Current ratio: 1.6177448400055408
Quick ratio: 1.3138938911206537
Buyback yield (%): 0
Retained earnings: 49684829.80809637
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8135.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 96758454.7520385
Buffett classification: The Gruesome
Stock price: 2.6663547654056945
Shares outstanding: 19574747
Book value: 97259724.63574389
P/B ratio: 0.5366375459167124
Market cap (USD): 52193219.94506082
Debt to equity: 0.00322979659153381
Current ratio: 1.5842703385244423
Quick ratio: 1.3185015934098974
Buyback yield (%): 0
Retained earnings: 64296217.083277635
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8135.T — annual report dated 2025-03-31
Total revenue: 369663146.63815
Gross profit: 64042240.34220024
Operating income: 7184868.333110547
Net income: 19997326.560620237
Capital expenditures: 280711.1348750167
Operating cash flow: 13681326.025932362
Depreciation & amortization: 875551.3968720759
Net tangible assets: 96758454.7520385
Owner earnings: 20592166.822617296
Return on net tangible assets (%): 21.282033570491123
Capex to operating income (%): 3.9069767441860463
Buffett classification: The Great
Stock price: 2.6663547654056945
P/E ratio: 2.6100098824131015
Shares outstanding: 19574747
Book value: 97259724.63574389
P/B ratio: 0.5366375459167124
Market cap (USD): 52193219.94506082
Debt to equity: 0.00322979659153381
Current ratio: 1.5842703385244423
Quick ratio: 1.3185015934098974
Effective tax rate (%): 29.159763313609467
Interest coverage ratio: 358.33333333333337
COGS to revenue (%): 82.67370590681445
SG&A to revenue (%): 2.748196496049467
Free cash flow (dilution-adjusted): 13327095.308113888
Buyback yield (%): 0
Retained earnings: 64296217.083277635
Inventory turnover: 10.345248868778281
Receivables turnover: 5.3263674884437595
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.665426587301587
FCF margin (%): 3.605199877054367
Revenue growth (%): 7.746380520202151
Rule of 40 score: 11.351580397256518
Financial ratios for 8135.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.7604483808469413
Shares outstanding: 19574747
Market cap (USD): 54035078.66163852
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 8135.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 98075370.12113056
Buffett classification: The Gruesome
Stock price: 3.253903095558546
Shares outstanding: 19574747
Book value: 98512786.0026918
P/B ratio: 0.6465590147489582
Market cap (USD): 63694329.858075365
Debt to equity: 0.020424892410683786
Current ratio: 1.6487490226739638
Quick ratio: 1.3674745895230649
Buyback yield (%): 0
Retained earnings: 64952893.67429341
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9006.T — annual report dated 2022-03-31
Total revenue: 2173717423.3732176
Gross profit: 338485494.18128175
Operating income: 28765776.102278315
Net income: 102679888.54286183
Capital expenditures: 131306343.22242256
Operating cash flow: 477216849.696771
Depreciation & amortization: 242312735.61711195
Net tangible assets: 2025881003.1142437
Owner earnings: 213686280.93755126
Return on net tangible assets (%): 10.547819966180958
Capex to operating income (%): 456.4672364672365
Buffett classification: The Gruesome
Stock price: 9.605884281265366
P/E ratio: 24.833598412453505
Shares outstanding: 265453033
Book value: 2105245041.7964277
P/B ratio: 1.2112182033370569
Market cap (USD): 2549911117.1089168
Debt to equity: 1.9061981765947003
Current ratio: 0.6355003325953357
Quick ratio: 0.39146471014564693
Effective tax rate (%): 38.522375595618215
Interest coverage ratio: 0.8983875095981572
COGS to revenue (%): 84.42826604131399
Free cash flow (dilution-adjusted): 141993115.88264218
Buyback yield (%): 0
Retained earnings: 1246516964.4320602
Inventory turnover: 4.5552278275020335
Receivables turnover: 21.562230712950164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.49371324403359496
FCF margin (%): 6.532271138642044
Rule of 40 score: 6.532271138642044
Financial ratios for 9006.T — annual report dated 2023-03-31
Total revenue: 1899436936.936937
Gross profit: 372432432.4324325
Operating income: 81231231.23123124
Net income: 118926426.42642644
Capital expenditures: 242289789.7897898
Operating cash flow: 186081081.0810811
Depreciation & amortization: 212530030.03003004
Net tangible assets: 1972852852.852853
Owner earnings: 89166666.66666669
Return on net tangible assets (%): 4.5196815635655145
Capex to operating income (%): 298.27171903881697
Buffett classification: The Gruesome
Stock price: 8.908033033033034
P/E ratio: 19.88342253053153
Shares outstanding: 265453033
Book value: 2052927927.927928
P/B ratio: 1.1518496847911868
Market cap (USD): 2364664386.682808
Debt to equity: 1.7825927957579084
Current ratio: 0.6047671417349344
Quick ratio: 0.34433396925148696
Effective tax rate (%): 29.124910522548316
Interest coverage ratio: 2.9684499314128945
COGS to revenue (%): 80.39248236200865
Free cash flow (dilution-adjusted): -233993993.99399403
Buyback yield (%): 0
Retained earnings: 1239969969.96997
Inventory turnover: 3.5057568340859735
Receivables turnover: 17.841125449545167
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.518287506402206
FCF margin (%): -12.319124127981661
Revenue growth (%): -12.618037813334846
Rule of 40 score: -24.937161941316507
Financial ratios for 9006.T — annual report dated 2024-03-31
Total revenue: 1853037506.6032753
Gross profit: 458267300.58108824
Operating income: 185162440.570523
Net income: 553433703.116746
Capital expenditures: 192855256.20707873
Operating cash flow: 437150026.4131009
Depreciation & amortization: 186014263.07448494
Net tangible assets: 2290841257.2636027
Owner earnings: 546592709.9841522
Return on net tangible assets (%): 23.859912084744543
Capex to operating income (%): 104.15463071930388
Buffett classification: The Gruesome
Stock price: 8.76472530375066
P/E ratio: 4.2039776439160255
Shares outstanding: 265453033
Book value: 2361958531.43159
P/B ratio: 0.985039696646277
Market cap (USD): 2326622915.292459
Debt to equity: 1.3625379163812745
Current ratio: 0.9332827169439006
Quick ratio: 0.6693426549709407
Effective tax rate (%): 29.7336496784849
Interest coverage ratio: 7.48758344459279
COGS to revenue (%): 75.26939962369576
Free cash flow (dilution-adjusted): -43911780.24300053
Buyback yield (%): 0
Retained earnings: 1620100369.7834127
Inventory turnover: 3.0842824601366745
Receivables turnover: 17.498534638648128
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.388910777173769
FCF margin (%): -2.369718912138662
Revenue growth (%): -2.4427992017721984
Rule of 40 score: -4.81251811391086
Financial ratios for 9006.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 2501246673.20353
Buffett classification: The Gruesome
Stock price: 7.865037120044824
Shares outstanding: 265453033
Book value: 2585004902.6474295
P/B ratio: 0.8076572528103402
Market cap (USD): 2087797958.1734836
Debt to equity: 1.2868591957993645
Current ratio: 0.9363373726424242
Quick ratio: 0.5496576449352832
Buyback yield (%): 0
Retained earnings: 1798627258.7197087
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9006.T — annual report dated 2025-03-31
Total revenue: 1964042240.3422003
Gross profit: 525417724.9030878
Operating income: 238230183.1305975
Net income: 163353829.7019115
Capital expenditures: 504645100.9223366
Operating cash flow: 99231386.1783184
Depreciation & amortization: 190756583.34447265
Net tangible assets: 2419689881.0319476
Owner earnings: -150534687.87595242
Return on net tangible assets (%): -6.2212388891651065
Capex to operating income (%): 211.8308831780945
Buffett classification: The Gruesome
Stock price: 9.81640155059484
P/E ratio: 15.951836387958348
Shares outstanding: 265453033
Book value: 2490208528.2716217
P/B ratio: 1.0464158062135887
Market cap (USD): 2605793564.751303
Debt to equity: 1.2729927399116978
Current ratio: 0.8670915872958389
Quick ratio: 0.531692499909463
Effective tax rate (%): 22.55631950825386
Interest coverage ratio: 8.609661835748792
COGS to revenue (%): 73.2481453753488
Free cash flow (dilution-adjusted): -430457158.1339393
Buyback yield (%): 0
Retained earnings: 1770933030.3435369
Inventory turnover: 2.9051706685022474
Receivables turnover: 14.9471007121058
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.353178538453647
FCF margin (%): -21.916899203702446
Revenue growth (%): 5.990420233986686
Rule of 40 score: -15.92647896971576
Financial ratios for 9006.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 2419689881.0319476
Buffett classification: The Gruesome
Stock price: 9.81640155059484
Shares outstanding: 265453033
Book value: 2490208528.2716217
P/B ratio: 1.0464158062135887
Market cap (USD): 2605793564.751303
Debt to equity: 1.2729927399116978
Current ratio: 0.8670915872958389
Quick ratio: 0.531692499909463
Buyback yield (%): 0
Retained earnings: 1770933030.3435369
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9006.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.099017437032936
Shares outstanding: 265453033
Market cap (USD): 2680814808.9802794
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9006.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 2510841184.387618
Buffett classification: The Gruesome
Stock price: 9.952086137281293
Shares outstanding: 265453033
Book value: 2579199192.462988
P/B ratio: 1.0242758517987107
Market cap (USD): 2641811449.818574
Debt to equity: 1.293010914005568
Current ratio: 1.0087994277479144
Quick ratio: 0.6023058392855264
Buyback yield (%): 0
Retained earnings: 1854253028.2637954
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9303.T — annual report dated 2022-03-31
Total revenue: 1896885756.4333715
Gross profit: 314915587.60858876
Operating income: 227421734.14194396
Net income: 191067038.1904606
Capital expenditures: 50647434.84674644
Operating cash flow: 257482379.93771514
Depreciation & amortization: 80888378.9542698
Net tangible assets: 1615644976.2334044
Owner earnings: 221307982.29798394
Return on net tangible assets (%): 13.697810196762722
Capex to operating income (%): 22.27027027027027
Buffett classification: The Great
Stock price: 16.17669234551713
P/E ratio: 6.4221564146332675
Shares outstanding: 75853727
Book value: 1753343714.1452224
P/B ratio: 0.6998413346113684
Market cap (USD): 1227062404.939846
Debt to equity: 0.4024389673885099
Current ratio: 1.6491293455080025
Quick ratio: 1.6486945358924983
Effective tax rate (%): 24.06032180313986
Interest coverage ratio: 81.14035087719299
COGS to revenue (%): 83.39828392192105
Free cash flow (dilution-adjusted): 202057039.82953614
Buyback yield (%): 1.6703828438215385
Retained earnings: 988846090.8047861
Inventory turnover: 9192
Receivables turnover: 8.551930537594679
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.527362847739711
FCF margin (%): 10.652040542992681
Rule of 40 score: 10.652040542992681
Financial ratios for 9303.T — annual report dated 2023-03-31
Total revenue: 1681268768.768769
Gross profit: 267364864.8648649
Operating income: 195885885.8858859
Net income: 209151651.65165168
Capital expenditures: 56208708.70870871
Operating cash flow: 223843843.84384388
Depreciation & amortization: 75315315.31531532
Net tangible assets: 1580983483.4834836
Owner earnings: 228258258.25825828
Return on net tangible assets (%): 14.437738321928705
Capex to operating income (%): 28.69461904031887
Buffett classification: The Good
Stock price: 14.702852852852855
P/E ratio: 5.332332676382498
Shares outstanding: 75853727
Book value: 1718798798.7987993
P/B ratio: 0.6488637222698126
Market cap (USD): 1115266186.4214716
Debt to equity: 0.3599613879376615
Current ratio: 1.8115525455762493
Quick ratio: 1.7545576249163288
Effective tax rate (%): 32.311280643358685
Interest coverage ratio: 77.8865671641791
COGS to revenue (%): 84.09788117618164
Free cash flow (dilution-adjusted): 127447447.44744746
Buyback yield (%): 2.0214945382128735
Retained earnings: 987642642.6426427
Inventory turnover: 65.05457685664939
Receivables turnover: 9.753277296285006
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.7887264662071605
FCF margin (%): 7.58043269552792
Revenue growth (%): -11.366893706346206
Rule of 40 score: -3.786461010818286
Financial ratios for 9303.T — annual report dated 2024-03-31
Total revenue: 1219340993.1325939
Gross profit: 147187004.75435817
Operating income: 87090596.93608029
Net income: 88622556.78816693
Capital expenditures: 148501056.52403593
Operating cash flow: 145496566.29688326
Depreciation & amortization: 65973322.768092975
Net tangible assets: 1637592445.8531432
Owner earnings: 6094823.03222397
Return on net tangible assets (%): 0.37218192155550184
Capex to operating income (%): 170.5133065433316
Buffett classification: The Gruesome
Stock price: 15.878301637612257
P/E ratio: 13.590539488970272
Shares outstanding: 75853727
Book value: 1748553882.7258322
P/B ratio: 0.6888139791068387
Market cap (USD): 1204428357.643093
Debt to equity: 0.34433404707686144
Current ratio: 2.0764923507649238
Quick ratio: 2.007149285071493
Effective tax rate (%): 25.989853314216386
Interest coverage ratio: 33.81794871794872
COGS to revenue (%): 87.9295125557114
Free cash flow (dilution-adjusted): -7402271.526677232
Buyback yield (%): 1.0043935062254286
Retained earnings: 887011357.6333861
Inventory turnover: 58.53208363374189
Receivables turnover: 8.94222760290557
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.322869322476292
FCF margin (%): -0.6070714893017864
Revenue growth (%): -27.47495131158924
Rule of 40 score: -28.08202280089103
Financial ratios for 9303.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 1718987253.116683
Buffett classification: The Gruesome
Stock price: 17.99796890320773
Shares outstanding: 75853727
Book value: 1838899005.46295
P/B ratio: 0.7424078297300024
Market cap (USD): 1365213019.7384086
Debt to equity: 0.3239741314300078
Current ratio: 2.1596258465637836
Quick ratio: 2.0837404241145774
Buyback yield (%): 0
Retained earnings: 949012466.7320353
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9303.T — annual report dated 2025-03-31
Total revenue: 1292567838.5242615
Gross profit: 155032749.6324021
Operating income: 88738136.6127523
Net income: 141251169.62972865
Capital expenditures: 87053869.8035022
Operating cash flow: 212090629.59497392
Depreciation & amortization: 70458494.85362919
Net tangible assets: 1715686405.5607538
Owner earnings: 124655794.67985564
Return on net tangible assets (%): 7.265651477789335
Capex to operating income (%): 98.10198086917225
Buffett classification: The Gruesome
Stock price: 17.94459296885443
P/E ratio: 9.636481310234219
Shares outstanding: 75853727
Book value: 1832255046.1168294
P/B ratio: 0.7428901664483734
Market cap (USD): 1361164256.1856034
Debt to equity: 0.2896673986474163
Current ratio: 1.6417234893016694
Quick ratio: 1.5894858531232856
Effective tax rate (%): 29.824677912073316
Interest coverage ratio: 28.925925925925924
COGS to revenue (%): 88.00634973163594
Free cash flow (dilution-adjusted): 118613821.68159337
Buyback yield (%): 1.9724302081290934
Retained earnings: 953014302.9006817
Inventory turnover: 63.84058514628657
Receivables turnover: 8.988798512665582
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.414769643862957
FCF margin (%): 9.17660320382225
Revenue growth (%): 6.005444400219943
Rule of 40 score: 15.182047604042193
Financial ratios for 9303.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 1715686405.5607538
Buffett classification: The Gruesome
Stock price: 17.94459296885443
Shares outstanding: 75853727
Book value: 1832255046.1168294
P/B ratio: 0.7428901664483734
Market cap (USD): 1361164256.1856034
Debt to equity: 0.2896673986474163
Current ratio: 1.6417234893016694
Quick ratio: 1.5894858531232856
Buyback yield (%): 0
Retained earnings: 953014302.9006817
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9303.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 19.949487960143923
Shares outstanding: 75853727
Market cap (USD): 1513243013.518544
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9303.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 1819226110.3633916
Buffett classification: The Gruesome
Stock price: 20.702153432032304
Shares outstanding: 75853727
Book value: 1942469717.362046
P/B ratio: 0.8084221240154373
Market cap (USD): 1570335494.7454915
Debt to equity: 0.27287277715996133
Current ratio: 1.4684613257121784
Quick ratio: 1.4199133400940351
Buyback yield (%): 0
Retained earnings: 978580080.7537012
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9532.T — annual report dated 2022-03-31
Total revenue: 13039829536.141617
Gross profit: 2579626290.7720046
Operating income: 812997869.2017702
Net income: 1113210949.02475
Capital expenditures: 1412506146.5333552
Operating cash flow: 1191198164.2353714
Depreciation & amortization: 892493033.9288641
Net tangible assets: 9640747418.455992
Owner earnings: 593197836.420259
Return on net tangible assets (%): 6.153027464288264
Capex to operating income (%): 173.74044878127458
Buffett classification: The Gruesome
Stock price: 15.412965087690543
P/E ratio: 5.265298111354522
Shares outstanding: 380289417
Book value: 10621939026.389118
P/B ratio: 0.5518189751303575
Market cap (USD): 5861387507.43919
Debt to equity: 0.5520454228066127
Current ratio: 1.7682875634073814
Quick ratio: 1.4048476973437616
Effective tax rate (%): -14.144300095796709
Interest coverage ratio: 9.538653846153846
COGS to revenue (%): 80.21733118809392
Free cash flow (dilution-adjusted): -349508277.331585
Buyback yield (%): 0
Retained earnings: 8014317325.028684
Inventory turnover: 8.77550964282031
Receivables turnover: 7.005697478843596
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.534127764756643
FCF margin (%): -2.680313238473528
Rule of 40 score: -2.680313238473528
Financial ratios for 9532.T — annual report dated 2023-03-31
Total revenue: 17080427927.927929
Gross profit: 2118776276.2762764
Operating income: 450465465.4654655
Net income: 439624624.62462467
Capital expenditures: 1291884384.3843844
Operating cash flow: 252042042.04204208
Depreciation & amortization: 899572072.0720721
Net tangible assets: 9656906906.906908
Owner earnings: 47312312.312312365
Return on net tangible assets (%): 0.48993236414522323
Capex to operating income (%): 286.78877370754304
Buffett classification: The Gruesome
Stock price: 15.128528528528529
P/E ratio: 13.0866629663759
Shares outstanding: 380289417
Book value: 10639474474.474474
P/B ratio: 0.5407428071738625
Market cap (USD): 5753219294.181982
Debt to equity: 0.5726408397533691
Current ratio: 1.6984327900512832
Quick ratio: 1.2213102275346999
Effective tax rate (%): 30.045394815434236
Interest coverage ratio: 4.556998556998557
COGS to revenue (%): 87.59529746434573
Free cash flow (dilution-adjusted): -1205525525.5255256
Buyback yield (%): 0.004958706955143945
Retained earnings: 7583168168.168169
Inventory turnover: 9.084200929893337
Receivables turnover: 8.13696969263453
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5426828053840356
FCF margin (%): -7.057935144320304
Revenue growth (%): 30.986589054613468
Rule of 40 score: 23.928653910293164
Financial ratios for 9532.T — annual report dated 2024-03-31
Total revenue: 13754952456.418385
Gross profit: 2709772847.332277
Operating income: 1139421553.0903327
Net income: 885677496.0380349
Capital expenditures: 16547807.712625463
Operating cash flow: 2064243264.659271
Depreciation & amortization: 815933703.116746
Net tangible assets: 9695377707.342842
Owner earnings: 1685063391.4421554
Return on net tangible assets (%): 17.380069578578297
Capex to operating income (%): 1.4522989904609573
Buffett classification: The Great
Stock price: 21.279384574749077
P/E ratio: 9.13687520598649
Shares outstanding: 380289417
Book value: 10598203909.138935
P/B ratio: 0.7635562424942615
Market cap (USD): 8092324754.050119
Debt to equity: 0.5075333708828454
Current ratio: 1.9355402908086592
Quick ratio: 1.3978184273587586
Effective tax rate (%): 31.57328190922216
Interest coverage ratio: 11.95303408146301
COGS to revenue (%): 80.29960874678956
Free cash flow (dilution-adjusted): 827013998.943476
Buyback yield (%): 1.6365542897486582
Retained earnings: 7249623613.312203
Inventory turnover: 7.896411239307362
Receivables turnover: 7.699970797739228
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.672129011352988
FCF margin (%): 6.012481697510861
Revenue growth (%): -19.46950911031985
Rule of 40 score: -13.45702741280899
Financial ratios for 9532.T — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 10890222720.268946
Buffett classification: The Gruesome
Stock price: 21.763062053508893
Shares outstanding: 380289417
Book value: 12015870570.10786
P/B ratio: 0.688777573973937
Market cap (USD): 8276262180.463719
Debt to equity: 0.5439390636420757
Current ratio: 1.7705004198738938
Quick ratio: 1.2898916129933002
Buyback yield (%): 0
Retained earnings: 7902192183.779241
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9532.T — annual report dated 2025-03-31
Total revenue: 13828492180.189814
Gross profit: 2710713808.3143964
Operating income: 1074261462.3713408
Net income: 902646704.9859644
Capital expenditures: 40375618.23285657
Operating cash flow: 1896009891.7257051
Depreciation & amortization: 852486298.6231787
Net tangible assets: 10669803502.205587
Owner earnings: 1714757385.3762867
Return on net tangible assets (%): 16.07112431847338
Capex to operating income (%): 3.758453565273656
Buffett classification: The Great
Stock price: 22.0910306108809
P/E ratio: 9.307057905974055
Shares outstanding: 380289417
Book value: 11624722630.664349
P/B ratio: 0.7226826324251779
Market cap (USD): 8400985151.9410515
Debt to equity: 0.49729343738339354
Current ratio: 1.9834278951157316
Quick ratio: 1.4831972863818834
Effective tax rate (%): 28.63725231175693
Interest coverage ratio: 10.483368118966867
COGS to revenue (%): 80.39757005614739
Free cash flow (dilution-adjusted): 409504076.9950541
Buyback yield (%): 3.187066148085122
Retained earnings: 7839994653.121241
Inventory turnover: 8.114860942401226
Receivables turnover: 6.509378578709589
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.759440148491081
FCF margin (%): 2.9613067835529785
Revenue growth (%): 0.5346417881445581
Rule of 40 score: 3.4959485716975367
Financial ratios for 9532.T — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 10669803502.205587
Buffett classification: The Gruesome
Stock price: 22.0910306108809
Shares outstanding: 380289417
Book value: 11624722630.664349
P/B ratio: 0.7226826324251779
Market cap (USD): 8400985151.9410515
Debt to equity: 0.49729343738339354
Current ratio: 1.9834278951157316
Quick ratio: 1.4831972863818834
Buyback yield (%): 0
Retained earnings: 7839994653.121241
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9532.T — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 24.966302241904234
Shares outstanding: 380289417
Market cap (USD): 9494420524.219555
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for 9532.T — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 10767543741.588156
Buffett classification: The Gruesome
Stock price: 28.59475100942127
Shares outstanding: 380289417
Book value: 11563687752.355316
P/B ratio: 0.9403817729701391
Market cap (USD): 10874281190.632977
Debt to equity: 0.497889853372161
Current ratio: 1.74874976499342
Quick ratio: 1.3245346869712353
Buyback yield (%): 0
Retained earnings: 8267772543.741589
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AAJ.AX — annual report dated 2021-06-30
Operating income: -1682345.864661654
Net income: -1200330.07518797
Capital expenditures: 6978.195488721804
Depreciation & amortization: 5024.812030075188
Net tangible assets: 2034417.2932330826
Owner earnings: -1202283.4586466167
Return on net tangible assets (%): -59.09719026896176
Buffett classification: The Gruesome
Stock price: 0.045112781954887216
Shares outstanding: 733768358
Book value: 2034417.2932330826
P/B ratio: 16.271161304986556
Market cap (USD): 33102331.939849623
Debt to equity: 0
Current ratio: 18.44984085207346
Quick ratio: 18.44984085207346
Free cash flow (dilution-adjusted): -1347930.827067669
Buyback yield (%): 0.42845038206639774
Retained earnings: -10478952.631578946
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -81.6649798512853
Rule of 40 score: 0
Financial ratios for AAJ.AX — annual report dated 2022-06-30
Operating income: -2552566.206896552
Net income: -2235643.4482758623
Capital expenditures: 13591.034482758621
Depreciation & amortization: 6387.586206896552
Net tangible assets: 2937466.896551724
Owner earnings: -2242846.896551724
Return on net tangible assets (%): -76.35309521903343
Buffett classification: The Gruesome
Stock price: 0.048275862068965524
Shares outstanding: 733768358
Book value: 2937466.8965517245
P/B ratio: 12.059131656245224
Market cap (USD): 35423300.04137932
Debt to equity: 0
Current ratio: 8.092196198160746
Quick ratio: 8.092196198160746
Free cash flow (dilution-adjusted): -1606107.5862068967
Buyback yield (%): 0.6264803102499392
Retained earnings: -11847373.103448275
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -86.89685013618347
Rule of 40 score: 0
Financial ratios for AAJ.AX — annual report dated 2023-06-30
Operating income: -2620603.3112582783
Net income: -2016717.8807947019
Capital expenditures: 19474.834437086094
Depreciation & amortization: 20243.70860927152
Net tangible assets: 2176314.569536424
Owner earnings: -2015949.0066225163
Return on net tangible assets (%): -92.6313242966495
Buffett classification: The Gruesome
Stock price: 0.026490066225165563
Shares outstanding: 733768358
Book value: 2176314.569536424
P/B ratio: 8.931416748954351
Market cap (USD): 19437572.397350993
Debt to equity: 0.008425143058850022
Current ratio: 17.26924791086351
Quick ratio: 17.26924791086351
Interest coverage ratio: -1198.7612844592547
Free cash flow (dilution-adjusted): -2351793.377483444
Buyback yield (%): 0.6329926807773305
Retained earnings: -13393334.437086092
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -120.1996588819042
Rule of 40 score: 0
Financial ratios for AAJ.AX — annual report dated 2024-06-30
Operating income: -1588828.6666666667
Net income: -750629.3333333334
Capital expenditures: 5665.333333333333
Depreciation & amortization: 23560
Net tangible assets: 1500054.6666666667
Owner earnings: -732734.6666666667
Return on net tangible assets (%): -48.847197568799714
Buffett classification: The Gruesome
Stock price: 0.006666666666666667
Shares outstanding: 733768358
Book value: 1500054.6666666667
P/B ratio: 3.2610738541973134
Market cap (USD): 4891789.053333334
Debt to equity: 0.0026127936670752444
Current ratio: 14.964129550538946
Quick ratio: 14.964129550538946
Interest coverage ratio: -1087.2458941605842
Free cash flow (dilution-adjusted): -661436.6666666666
Buyback yield (%): 0.5066312766787362
Retained earnings: -14054078
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -105.91805098658627
Rule of 40 score: 0
Financial ratios for AARTIDRUGS.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.59013583014638
Shares outstanding: 91270000
Market cap (USD): 510211697.2174601
Buyback yield (%): 0
Retained earnings: 115884161.94118424
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AARTIDRUGS.NS — annual report dated 2023-03-31
Total revenue: 329545408.0389769
Gross profit: 58826930.5724726
Operating income: 32442082.82582217
Net income: 20262752.740560293
Capital expenditures: 20057539.58587089
Operating cash flow: 16238879.415347138
Depreciation & amortization: 6129622.411693058
Net tangible assets: 142278392.2046285
Owner earnings: 6334835.56638246
Return on net tangible assets (%): 4.452422794651442
Capex to operating income (%): 61.8256839228157
Buffett classification: The Good
Stock price: 4.07442143727162
P/E ratio: 18.35251356719156
Shares outstanding: 91270000
Book value: 145270158.34348357
P/B ratio: 2.559868102439237
Market cap (USD): 371872444.57978076
Debt to equity: 0.5105481994989385
Current ratio: 1.5711681724603996
Quick ratio: 1.027404663050852
Effective tax rate (%): 25.793718588593823
Interest coverage ratio: 8.00011714103781
COGS to revenue (%): 82.14906682434643
SG&A to revenue (%): 3.089680472986114
Free cash flow (dilution-adjusted): -3836370.2801461634
Buyback yield (%): 0
Retained earnings: 124303885.50548112
Inventory turnover: 4.304934039136843
Receivables turnover: 3.1284056041863044
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.0953653018494
FCF margin (%): -1.1641401113659025
Rule of 40 score: -1.1641401113659025
Financial ratios for AARTIDRUGS.NS — annual report dated 2024-03-31
Total revenue: 300859911.26034296
Gross profit: 102033817.00443698
Operating income: 33301774.793140665
Net income: 20576891.71363473
Capital expenditures: 22448.734860295
Operating cash flow: 43041515.769276895
Depreciation & amortization: 6169480.753087901
Net tangible assets: 149266039.09341648
Owner earnings: 26723923.731862336
Return on net tangible assets (%): 17.903552538925123
Capex to operating income (%): 0.06741002544080288
Buffett classification: The Great
Stock price: 5.169865642994242
P/E ratio: 22.931239751989516
Shares outstanding: 91270000
Book value: 153729979.61386257
P/B ratio: 3.06936642040337
Market cap (USD): 471853637.2360844
Debt to equity: 0.44017169722820854
Current ratio: 1.6601496060488015
Quick ratio: 1.0493812588563756
Effective tax rate (%): 27.146307145058884
Interest coverage ratio: 8.28471062052506
COGS to revenue (%): 80.67396296373651
SG&A to revenue (%): 2.8647230459216955
Free cash flow (dilution-adjusted): 15899832.114162369
Buyback yield (%): 1.5210478403304386
Retained earnings: 138535603.7894232
Inventory turnover: 4.165543475375098
Receivables turnover: 3.56093674065394
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.966086521796324
FCF margin (%): 5.284795853178251
Revenue growth (%): -8.704565768138751
Rule of 40 score: -3.4197699149605008
Financial ratios for AARTIDRUGS.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 152312470.1385571
Buffett classification: The Gruesome
Stock price: 6.082775919732441
Shares outstanding: 91270000
Book value: 152626493.07214525
P/B ratio: 3.63747437957284
Market cap (USD): 555174958.1939799
Debt to equity: 0.46181333537853275
Current ratio: 1.6078145203620489
Quick ratio: 1.0061066943196222
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AARTIDRUGS.NS — annual report dated 2025-03-31
Total revenue: 279054243.6287117
Gross profit: 98776011.22281973
Operating income: 27037643.207855973
Net income: 19658639.233107317
Capital expenditures: 20704933.36450783
Operating cash flow: 28592471.358428802
Depreciation & amortization: 6520925.88262801
Net tangible assets: 152654980.1262567
Owner earnings: 5474631.751227494
Return on net tangible assets (%): 3.586277857885526
Capex to operating income (%): 76.57817364233829
Buffett classification: The Gruesome
Stock price: 3.950052514879216
P/E ratio: 18.339076716249433
Shares outstanding: 91270000
Book value: 160082160.3927987
P/B ratio: 2.252101621744756
Market cap (USD): 360521293.03302604
Debt to equity: 0.4491721868329829
Current ratio: 1.5990538692813143
Quick ratio: 1.0340036187815334
Effective tax rate (%): 20.621428908721725
Interest coverage ratio: 6.447727906328409
COGS to revenue (%): 64.60329363267323
SG&A to revenue (%): 3.5583130501082936
Free cash flow (dilution-adjusted): 7881692.775309796
Buyback yield (%): 1.9407249482312257
Retained earnings: 144992506.42974046
Inventory turnover: 3.26074798230514
Receivables turnover: 3.1777248415084722
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.309459787166041
FCF margin (%): 2.82443035906545
Revenue growth (%): -7.247781048756
Rule of 40 score: -4.42335068969055
Financial ratios for AARTIDRUGS.NS — quarterly report dated 2025-03-31
Total revenue: 79116202.94599018
Gross profit: 28198503.624035537
Operating income: 9168809.913490765
Net income: 7348608.83797054
Capital expenditures: 0
Depreciation & amortization: 1739537.0586859947
Net tangible assets: 152654980.1262567
Owner earnings: 9088145.896656536
Return on net tangible assets (%): 5.95338972180271
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.950052514879216
P/E ratio: 12.264950447838471
Shares outstanding: 91270000
Book value: 160082160.3927987
P/B ratio: 2.252101621744756
Market cap (USD): 360521293.03302604
Debt to equity: 0.4491721868329829
Current ratio: 1.5990538692813143
Quick ratio: 1.0340036187815334
Effective tax rate (%): 11.777933942375263
Interest coverage ratio: 8.562227074235809
COGS to revenue (%): 64.35811809208583
Buyback yield (%): 0
Retained earnings: 144992506.42974046
Inventory turnover: 0.9209641292348122
Receivables turnover: 0.9009342420243037
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.513407692439609
Rule of 40 score: 0
Financial ratios for AARTIDRUGS.NS — quarterly report dated 2025-06-30
Total revenue: 69097823.5431781
Gross profit: 25406037.912473675
Operating income: 6945939.620875264
Net income: 6315235.197753335
Capital expenditures: 0
Depreciation & amortization: 1722443.2483033
Owner earnings: 8037678.446056635
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.332319213667213
P/E ratio: 19.26613813229572
Shares outstanding: 91270000
Market cap (USD): 486680774.63140655
Effective tax rate (%): -5.595773821170025
Interest coverage ratio: 6.934579439252337
COGS to revenue (%): 63.23178269631335
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -12.662866808270955
Rule of 40 score: -12.662866808270955
Financial ratios for AARTIDRUGS.NS — quarterly report dated 2025-09-30
Total revenue: 73595264.93799323
Gross profit: 27564825.253664035
Operating income: 7669673.055242389
Net income: 5104847.801578354
Capital expenditures: 0
Depreciation & amortization: 1833145.4340473507
Net tangible assets: 164418263.8105975
Owner earnings: 6937993.235625705
Return on net tangible assets (%): 4.219721747954937
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 5.455467869222097
P/E ratio: 26.529315774384347
Shares outstanding: 91270000
Book value: 165568207.44081175
P/B ratio: 3.0073439830041053
Market cap (USD): 497920552.4239008
Debt to equity: 0.39050381658597694
Current ratio: 1.676442786705158
Quick ratio: 1.076028919602483
Effective tax rate (%): 25.24416487336534
Interest coverage ratio: 8.835064935064935
COGS to revenue (%): 62.54538212901546
Buyback yield (%): 0
Inventory turnover: 0.8686282018551612
Receivables turnover: 0.9071567537520844
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.718685259181921
Revenue growth (%): 6.508803264989606
Rule of 40 score: 6.508803264989606
Financial ratios for AARTIDRUGS.NS — quarterly report dated 2025-12-31
Total revenue: 67027960.343099035
Gross profit: 23957892.391667597
Operating income: 4131669.822880695
Net income: 4517099.253648212
Capital expenditures: 0
Depreciation & amortization: 1999554.4168430434
Owner earnings: 6516653.670491256
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.561100590397683
P/E ratio: 17.877496592648722
Shares outstanding: 91270000
Market cap (USD): 416291650.8855966
Effective tax rate (%): -39.73121984838043
Interest coverage ratio: 3.9924650161463937
COGS to revenue (%): 64.25686792640974
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -8.923542296406424
Rule of 40 score: -8.923542296406424
Financial ratios for ABLBL.NS — quarterly report dated 2025-06-30
Total revenue: 215373274.0463375
Gross profit: 134830329.97893754
Operating income: 64913409.782354325
Net income: 2815352.2115609646
Capital expenditures: 0
Depreciation & amortization: 20186051.95413059
Owner earnings: 23001404.165691555
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.8380528902410487
P/E ratio: 198.24954931097255
Shares outstanding: 1214638186
Market cap (USD): 2232569228.3744445
Effective tax rate (%): 14.589989350372736
Interest coverage ratio: 6.528774861715901
COGS to revenue (%): 37.39690749655
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -5.141544147116051
Rule of 40 score: -5.141544147116051
Financial ratios for ABLBL.NS — quarterly report dated 2025-12-31
Total revenue: 261019271.4715384
Gross profit: 153033307.34098253
Operating income: 77632839.4786677
Net income: 7687423.4153948985
Capital expenditures: 0
Depreciation & amortization: 22689094.352233488
Owner earnings: 30376517.767628387
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.4211874791132895
P/E ratio: 78.39953157100156
Shares outstanding: 1214638186
Market cap (USD): 1726228581.5960789
Effective tax rate (%): 23.754281294884542
Interest coverage ratio: 7.308200503355705
COGS to revenue (%): 41.37087791325427
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 21.193900509391984
Rule of 40 score: 21.193900509391984
Financial ratios for ALGT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 180.78
Shares outstanding: 26877500
Market cap (USD): 4858914450
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ALGT — annual report dated 2022-12-31
Total revenue: 2301829000
Gross profit: 340468000
Operating income: 126258000
Net income: 2493000
Capital expenditures: 433370000
Operating cash flow: 303050000
Depreciation & amortization: 197542000
Net tangible assets: 1220698000
Owner earnings: -233335000
Return on net tangible assets (%): -19.114883451926683
Capex to operating income (%): 343.2416163728239
Buffett classification: The Gruesome
Stock price: 65.71
P/E ratio: 708.4318190934616
Shares outstanding: 26877500
Book value: 1220698000
P/B ratio: 1.4468120083755358
Market cap (USD): 1766120524.9999998
Debt to equity: 1.8120149291634786
Current ratio: 1.4649615844917
Quick ratio: 1.42409617500411
Effective tax rate (%): 49.66686856450636
Interest coverage ratio: 1.2249614343510784
COGS to revenue (%): 85.20880569321179
SG&A to revenue (%): 4.3738262051612
Free cash flow (dilution-adjusted): -146838000
Buyback yield (%): 1.693259297804718
Retained earnings: 1169968000
Inventory turnover: 55.17810724132111
Receivables turnover: 21.597599879900166
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.467229956286836
FCF margin (%): -6.379188028302711
Rule of 40 score: -6.379188028302711